EUVIMEDEUVIMED entdecken
Crossref

L26/O-161 The outcomes of assisted reproductive technology with preimplantation genetic testing for aneuploidy in women aged 40 and older using their own oocytes

Y. Alhelou, M. Fakih

Human Reproduction · 01.07.2026 · 41 (Supplement_1)

DOI: 10.1093/humrep/deag083.159 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von Y. Alhelou und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Study question What is the blastulation rate, euploidy rate and pregnancy rate rate in patients aged 40 and older utilising their own eggs. Summary answer Euploid blastocysts are still available for frozen embryo transfer cycles to women over 40, despite a fall in blastulation and euploidy rates with advancing age. What is known already Women over 40 undergoing IVF with Preimplantation Genetic Testing for Aneuploidy (PGT-A) exhibit age-related decreases in reproductive capacity. The quality of oocytes diminishes as a result of mitochondrial dysfunction, spindle irregularities, and increased chromosomal segregation errors during meiosis. These abnormalities result in diminished fertilisation and blastulation rates, as embryos are less likely to advance to the blastocyst stage. Advanced mother age is significantly correlated with increased rates of embryonic aneuploidy, resulting in diminished euploid blastocyst yield, even at the biopsy stage of embryo development. Consequently, the availability of transferred embryos diminishes, implantation rates decrease, and the chance of miscarriage escalates. Study design, size, duration This retrospective cohort study examined 2448 ICSI cycles with PGT-A at three referral fertility facilities from January 2021 to December 2023. Frozen embryo transfer (FET) was done when euploid blastocysts were available. The average oocytes, biopsied blastocysts, euploid blastocysts, and pregnancy rate were examined. The p-value was calculated for the number of oocytes, blastocysts, euploid blastocysts and pregnancy rate per age group. The linear regression between age and average number of euploid blastocysts was estimated. Participants/materials, setting, methods The patients were divided into seven groups. The 40-year age group has 525 patients and 319 FET; The 41-year age group contained 411 patients and 312 FET; The 42-year age group had 390 patients and 82 FET; The 43-year age group had 345 patients and 41 FET; The 44-year age group had 312 patients and 26 FET; The 45-year age group had 261 patients and 10 FET,whereas the 46-year group had 204 and 9 FET. Main results and the role of chance The average number of oocytes is: 7.7±2.3 in 40-year, 8.3±2.4 in 41-year, 6.4±2.1 in 42-year, 5.0±2.5 in 43-year, 5.0±2.4 in 44-year, 4.4±2.4 in 45-year, 3.9±2.1 in 46-year (p < 0.0001). The average number of biopsied blastocysts was 1.7±1.4 in 40-year, 1.0±1.3 in 41-year, 1.0±1.1 in 42-year, 0.95±0.87 in 43-year, 0.81±0.60 in 44-year, 0.46±0.42 in 45-year, and 0.40±0.29 in 46-year (p < 0.0001). The average number of euploid blastocysts was 0.8±0.4 in 40-year, 0.4±0.4 in 41-year, 0.24±0.21 in 42-year, 0.13±0.12 in 43-year, 0.09±0.04 in 44-year, 0.04±0.02 in 45-year, and 0.05 ±0.03 in 46-years (p < 0.0001). The pregnancy rate was 70.5% in the 40-year group, 72.7% in the 41-year group, 68.3% in the 42-year group, 73.2% 43-year, 65.4% in the 44-year, 60.0% in the 45-year, 66.7% in the 46-year. p = 0.9412. The linear regression analysis correlating age with the average number of euploid blastocysts is represented by the equation: Euploid blastocyst = 5.04 − 0.11 × Age. This indicates that each incremental year of age results in an average decrease of 0.11 euploid blastocysts, corresponding to a 13.9% reduction in euploid blastocysts per year of age increase. Limitations, reasons for caution Findings should be interpreted with caution due to the retrospective design and lack of adjustment for confounding variables such as ovarian reserve, stimulation methods, and laboratory variability. Limited sample sizes for FET cycles in older demographics. Wider implications of the findings These findings endorse realistic counselling for women aged ≥40 concerning anticipated euploid embryo yield and the probable necessity for numerous IVF cycles. Outcomes facilitate clinical decision-making, therapeutic planning, and fiscal forecasting. They also influence healthcare policy and insurance coverage regarding PGT-A utilisation in populations of advanced maternal age. Trial registration number No

Zitieren

APA

Alhelou, Y., & Fakih, M. (2026). L26/O-161 The outcomes of assisted reproductive technology with preimplantation genetic testing for aneuploidy in women aged 40 and older using their own oocytes. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.159

Vancouver

Alhelou Y, Fakih M. L26/O-161 The outcomes of assisted reproductive technology with preimplantation genetic testing for aneuploidy in women aged 40 and older using their own oocytes. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.159

BibTeX
@article{Alhelou2026,
  author = {Alhelou, Y. and Fakih, M.},
  title = {L26/O-161 The outcomes of assisted reproductive technology with preimplantation genetic testing for aneuploidy in women aged 40 and older using their own oocytes},
  journal = {Human Reproduction},
  year = {2026},
  volume = {41},
  number = {Supplement_1},
  doi = {10.1093/humrep/deag083.159}
}
Kostenlos starten →